Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
The use of molecular biomarkers for COVID-19 remains unconclusive. The application of a molecular biomarker in combination with clinical ones that could help classifying aggressive patients in first steps of t...
![](https://static-content.springer.com/image/art%3A10.1186%2Fs40246-023-00496-2/MediaObjects/40246_2023_496_Figa_HTML.png)